Effect of kramecyne on the inflammatory response in lipopolysaccharide- stimulated peritoneal macrophages

Evidence-based Complementary and Alternative Medicine

Volumn 2013, Issue , 2013, Pages

  Sanchez Miranda E ^a   Lemus Bautista, J ^a   Perez S ^a   Perez Ramos J ^a  

^a DEPARTAMENTO DE SISTEMAS BIOLÓGICOS   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; CYCLOOXYGENASE 2; INTERLEUKIN 6; KRAMECYNE; LIPOPOLYSACCHARIDE; MESSENGER RNA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; GENE EXPRESSION; INFLAMMATION; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 84876561761     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2013/762020     Document Type: Article

References (57)

1. Dung N. T., Bajpai V. K., Yoon J. I., Kang S. C., Anti-inflammatory effects of essential oil isolated from the buds of Cleistocalyx operculatus (Roxb.) Merr and Perry. Food and Chemical Toxicology 2009 47 2 449 453 2-s2.0-58249105359 10.1016/j.fct.2008.11.033
2. Nathan C., Points of control in inflammation. Nature 2002 420 6917 846 852 2-s2.0-0037180812 10.1038/nature01320 (Pubitemid 36019637)
3. Rankin J. A., Biological mediators of acute inflammation. Advanced Critical Care 2004 15 1 3 17
4. Stuehr D. J., Marletta M. A., Mammalian nitrate biosynthesis: mouse macrophages produce nitrite and nitrate in response to Escherichia coli lipopolysaccharide. Proceedings of the National Academy of Sciences of the United States of America 1985 82 22 7738 7742 2-s2.0-0001509578 (Pubitemid 16204424)
5. Kanno S. I., Shouji A., Tomizawa A., Hiura T., Osanai Y., Ujibe M., Obara Y., Nakahata N., Ishikawa M., Inhibitory effect of naringin on lipopolysaccharide (LPS)-induced endotoxin shock in mice and nitric oxide production in RAW 264.7 macrophages. Life Sciences 2006 78 7 673 681 2-s2.0-29244477511 10.1016/j.lfs.2005.04.051 (Pubitemid 41821123)
6. Lee M. Y., Lee J. A., Seo C. S., Ha H., Lee H., Son J. K., Shin H. K., Anti-inflammatory activity of Angelica dahurica ethanolic extract on RAW264.7 cells via upregulation of heme oxygenase-1. Food and Chemical Toxicology 2011 49 5 1047 1055 2-s2.0-79953047271 10.1016/j.fct.2011.01.010
7. Davis K. L., Martin E., Turko I. V., Murad F., Novel effects of nitric oxide. Annual Review of Pharmacology and Toxicology 2001 41 203 236 2-s2.0-0035035184 10.1146/annurev.pharmtox.41.1.203 (Pubitemid 32385888)
8. Gautam R., Jachak S. M., Recent developments in anti-inflammatory natural products. Medicinal Research Reviews 2009 29 5 767 820 2-s2.0-69449105731 10.1002/med.20156
9. Pérez S., Sánchez E., Martínez M., Zavala M. A., Pérez C., Kramecyne-a new anti-inflammatory compound isolated from Krameria cytisoides. Molecules 2012 17 2049 2057
10. Elmann A., Mordechay S., Erlank H., Telerman A., Rindner M., Ofir R., Anti-Neuroinflammatory effects of the extract of Achillea fragrantissima. BMC Complementary and Alternative Medicine 2011 11 98
11. Ahn K. S., Noh E. J., Zhao H. L., Jung S. H., Kang S. S., Kim Y. S., Inhibition of inducible nitric oxide synthase and cyclooxygenase II by Platycodon grandiflorum saponins via suppression of nuclear factor- B activation in RAW 264.7 cells. Life Sciences 2005 76 20 2315 2328 2-s2.0-14644424029 10.1016/j.lfs.2004.10.042 (Pubitemid 40313419)
12. Ialenti A., Moncada S., Di Rosa M., Modulation of adjuvant arthritis by endogenous nitric oxide. British Journal of Pharmacology 1993 110 2 701 706 2-s2.0-0027257328 (Pubitemid 23279281)
13. Dobrovolskaia M. A., Vogel S. N., Toll receptors, CD14, and macrophage activation and deactivation by LPS. Microbes and Infection 2002 4 9 903 914 2-s2.0-0036067659 10.1016/S1286-4579(02)01613-1 (Pubitemid 34775232)
14. Adams D. O., Hamilton T. A., The cell biology of macrophage activation. Annual Review of Immunology 1984 2 283 318 2-s2.0-0021564388
15. Larsen G. L., Henson P. M., Mediators of inflammation. Annual Review of Immunology 1983 1 335 359 2-s2.0-0020976095
16. Lawrence T., Willoughby D. A., Gilroy D. W., Anti-inflammatory lipid mediators and insights into the resolution of inflammation. Nature Reviews Immunology 2002 2 10 787 795 2-s2.0-0036779617 10.1038/nri915 (Pubitemid 37328718)
17. Guzik T. J., Korbut R., Adamek-Guzik T., Nitric oxide and superoxide in inflammation and immune regulation. Journal of Physiology and Pharmacology 2003 54 4 469 487 2-s2.0-0347993913 (Pubitemid 38029745)
18. Nathan C., Points of control in inflammation. Nature 2002 420 6917 846 852 2-s2.0-0037180812 10.1038/nature01320 (Pubitemid 36019637)
19. Rankin J. A., Biological mediators of acute inflammation. AACN Clinical Issues 2004 15 1 3 17 2-s2.0-1842611825
20. Kazłowska K., Hsu T., Hou C. C., Yang W. C., Tsai G. J., Anti-inflammatory properties of phenolic compounds and crude extract from Porphyra dentata. Journal of Ethnopharmacology 2010 128 1 123 130 2-s2.0-76749145986 10.1016/j.jep.2009.12.037
21. Michelini F. M., Ramírez J. A., Berra A., Galagovsky L. R., Alché L. E., Anti-herpetic and anti-inflammatory activities of two new synthetic 22,23-dihydroxylated stigmastane derivatives. Journal of Steroid Biochemistry and Molecular Biology 2008 111 1-2 111 116 2-s2.0-48049083074 10.1016/j.jsbmb.2008.05.005
22. Mueller M., Hobiger S., Jungbauer A., Anti-inflammatory activity of extracts from fruits, herbs and spices. Food Chemistry 2010 122 4 987 996 2-s2.0-77951939535 10.1016/j.foodchem.2010.03.041
23. Paulino N., Rodrigues N. C., Pardi P. C., Suárez J. A. P. Q., Santos R. P. D., Scremin A., Vogel C., Feist H., Michalik D., Evaluation of anti-inflammatory effect of synthetic 1,5-bis(4-acetoxy-3-methoxyphenyl)-1,4- pentadien-3-one, HB2. Bioorganic and Medicinal Chemistry 2009 17 13 4290 4295 2-s2.0-66549091731 10.1016/j.bmc.2009.05.034
24. Prawan A., Saw C. L. L., Khor T. O., Keum Y. S., Yu S., Hu L., Kong A. N., Anti-NF- B and anti-inflammatory activities of synthetic isothiocyanates: effect of chemical structures and cellular signaling. Chemico-Biological Interactions 2009 179 2-3 202 211 2-s2.0-62549085979 10.1016/j.cbi.2008.12.014
25. Van Q., Nayak B. N., Reimer M., Jones P. J. H., Fulcher R. G., Rempel C. B., Anti-inflammatory effect of Inonotus obliquus, Polygala senega L., and Viburnum trilobum in a cell screening assay. Journal of Ethnopharmacology 2009 125 3 487 493 2-s2.0-69949106675 10.1016/j.jep.2009.06.026
26. Li C. Q., He L. C., Jin J. Q., Atractylenolide I and atractylenolide III inhibit lipopolysaccharide- induced TNF- α and NO production in macrophages. Phytotherapy Research 2007 21 4 347 353 2-s2.0-34247131353 10.1002/ptr.2040 (Pubitemid 46595979)
27. Ponnuchamy B., Khalil R. A., Cellular mediators of renal vascular dysfunction in hypertension. American Journal of Physiology 2009 296 4 R1001 R1018 2-s2.0-66049099352 10.1152/ajpregu.90960.2008
28. Zulkhurnain U., Mohamed I. A. M., Mohd I. A., Mohd F. A. J., Tan M. L., Mitragynine inhibits the COX-2 mRNA expression and prostaglandin E2 production induced by lipopolysaccharide in RAW 264.7 macrophage cells. Journal of Ethnopharmacology 2011 136 1 75 82 2-s2.0-79958102314 10.1016/j.jep.2011.04.011
29. Ialenti A., Ianaro A., Moncada S., Di Rosa M., Modulation of acute inflammation by endogenous nitric oxide. European Journal of Pharmacology 1992 211 2 177 182 2-s2.0-0026516107 10.1016/0014-2999(92)90526-A
30. Iuvone T., Carnuccio R., Di Rosa M., Modulation of granuloma formation by endogenous nitric oxide. European Journal of Pharmacology 1994 265 1-2 89 92 2-s2.0-0027967601 10.1016/0014-2999(94)90227-5 (Pubitemid 24341661)
31. Klosterhalfen B., Bhardwaj R. S., Septic shock. General Pharmacology 1998 31 1 25 32 2-s2.0-0032126564 10.1016/S0306-3623(97)00424-2 (Pubitemid 28239749)
32. Clancy R. M., Abramson S. B., Nitric oxide: a novel mediator of inflammation. Proceedings of the Society for Experimental Biology and Medicine 1995 210 2 93 101 2-s2.0-0028829119
33. Sarkar D., Saha P., Gamre S., Bhattacharjee S., Hariharan C., Ganguly S., Sen R., Mandal G., Chattopadhyay S., Majumdar S., Chatterjee M., Anti-inflammatory effect of allylpyrocatechol in LPS-induced macrophages is mediated by suppression of iNOS and COX-2 via the NF- B pathway. International Immunopharmacology 2008 8 9 1264 1271 2-s2.0-46349093408 10.1016/j.intimp.2008. 05.003
34. Epe B., Ballmaier D., Roussyn I., Briviba K., Sies H., DNA damage by peroxynitrite characterized with DNA repair enzymes. Nucleic Acids Research 1996 24 21 4105 4110 2-s2.0-0029862775 10.1093/nar/24.21.4105 (Pubitemid 26377321)
35. Nurul Islam Md., Joo Choi R., Eun Jin S., Mechanism of anti-inflammatory activity of umbelliferone 6-carboxylic acid isolated from Angelica decursiva. Journal of Ethnopharmacology 2012 144 175 181
36. Marletta M. A., Nitric oxide synthase structure and mechanism. Journal of Biological Chemistry 1993 268 17 12231 12234 2-s2.0-0027325255 (Pubitemid 23182366)
37. Nathan C., Xie Q. W., Regulation of biosynthesis of nitric oxide. Journal of Biological Chemistry 1993 269 19 13725 13728 2-s2.0-0028270719 (Pubitemid 24191108)
38. Alderton W. K., Cooper C. E., Knowles R. G., Nitric oxide synthases: structure, function and inhibition. Biochemical Journal 2001 357 3 593 615 2-s2.0-0035425503 10.1042/0264-6021:3570593 (Pubitemid 32735142)
39. Sung C. S., Wong C. S., Cellular mechanisms of neuroinflammatory pain: the role of interleukin-1 β Acta Anaesthesiologica Taiwanica 2007 45 2 103 109 2-s2.0-34548380873
40. Vuolteenaho K., Moilanen T., Knowles R. G., Moilanen E., The role of nitric oxide in osteoarthritis. Scandinavian Journal of Rheumatology 2007 36 4 247 258 2-s2.0-36048978070
41. Harbrecht B. G., Di Silvio M., Demetris A. J., Simmons R. L., Billiar T. R., Tumor necrosis factor- α regulates in vivo nitric oxide synthesis and induces liver injury during endotoxemia. Hepatology 1994 20 4 I 1055 1060 2-s2.0-0028169248
42. Tsatsanis C., Androulidaki A., Venihaki M., Margioris A. N., Signalling networks regulating cyclooxygenase-2. International Journal of Biochemistry and Cell Biology 2006 38 10 1654 1661 2-s2.0-33745388145 10.1016/j.biocel.2006.03. 021 (Pubitemid 43947653)
43. Aronoff D., Neilso E., Antipyretics: mechanism of action and clinical use in fever suppression. American Journal of Medicine 2001 327 749 754
44. Masferrer J. L., Zweifel B. S., Manning P. T., Hauser S. D., Leahy K. M., Smith W. G., Isakson P. C., Seibert K., Selective inhibition of inducible cyclooxygenase 2 in vivo is anti inflammatory and nonulcerogenic. Proceedings of the National Academy of Sciences of the United States of America 1994 91 8 3228 3232 2-s2.0-0028322893 (Pubitemid 24130209)
45. Van Q., Nayak B. N., Reimer M., Jones P. J. H., Fulcher R. G., Rempel C. B., Anti-inflammatory effect of Inonotus obliquus, Polygala senega L., and Viburnum trilobum in a cell screening assay. Journal of Ethnopharmacology 2009 125 3 487 493 2-s2.0-69949106675 10.1016/j.jep.2009.06.026
46. Clàiria J., Cyclooxygenase-2 biology. Current Pharmaceutical Design 2003 9 27 2177 2190 2-s2.0-0141538107 10.2174/1381612033454054 (Pubitemid 37139092)
47. Allison M. C., Howatson A. G., Torrance C. J., Lee F. D., Russell R. I., Gastrointestinal damage associated with the use of nonsteroidal antiinflammatory drugs. The New England Journal of Medicine 1992 327 11 749 754 2-s2.0-0026788165
48. Eberhart C. E., Dubois R. N., Eicosanoids and the gastrointestinal tract. Gastroenterology 1995 109 1 285 301 2-s2.0-0029021758 10.1016/0016-5085(95) 90296-1
49. Holtmann H., Resch K., Cytokine. Die Naturwissenchaften 1995 82 178 187
50. Beutler B., Cerami A., The biology of cachectin/TNF- α primary mediator of the host response. Annual Review of Immunology 1989 7 625 655 2-s2.0-0024405827 (Pubitemid 19138027)
51. Hseu Y. C., Wu F. Y., Wu J. J., Chen J. Y., Chang W. H., Lu F. J., Lai Y. C., Yang H. L., Anti-inflammatory potential of Antrodia Camphorata through inhibition of iNOS, COX-2 and cytokines via the NF- B pathway. International Immunopharmacology 2005 5 13-14 1914 1925 2-s2.0-27744488414 10.1016/j.intimp.2005.06.013 (Pubitemid 41586230)
52. Garlanda C., Di Liberto D., Vecchi A., La Manna M. P., Buracchi C., Caccamo N., Salerno A., Dieli F., Mantovani A., Damping excessive inflammation and tissue damage in Mycobacterium tuberculosis infection by toll IL-1 receptor 8/single Ig IL-1-related receptor, a negative regulator of IL-1/TLR signaling. Journal of Immunology 2007 179 5 3119 3125 2-s2.0-38449105679
53. Park S. J., Jung J. A., Lee S. J., Kim H. M., The phosphatidylinositol 3 kinase inhibitor, LY294002, block TNF- α and IL-6 production in activated RAW-264. 7 cells. Bulletin of Life Science and Biotechnology 1999 6 3 17
54. Van Q., Nayak B. N., Reimer M., Jones P. J. H., Fulcher R. G., Rempel C. B., Anti-inflammatory effect of Inonotus obliquus, Polygala senega L., and Viburnum trilobum in a cell screening assay. Journal of Ethnopharmacology 2009 125 3 487 493 2-s2.0-69949106675 10.1016/j.jep.2009.06.026
55. Marcus J. S., Karackattu S. L., Fleegal M. A., Sumners C., Cytokine-stimulated inducible nitric oxide synthase expression in astroglia: role of Erk mitogen-activated protein kinase and NF- B. GLIA 2003 41 2 152 160 2-s2.0-0037440375 10.1002/glia.10168 (Pubitemid 36262192)
56. Schrader L. I., Kinzenbaw D. A., Johnson A. W., Faraci F. M., Didion S. P., IL-6 deficiency protects against angiotensin II-induced endothelial dysfunction and hypertrophy. Arteriosclerosis, Thrombosis, and Vascular Biology 2007 27 12 2576 2581 2-s2.0-36349024339 10.1161/ATVBAHA.107.153080 (Pubitemid 350158908)
57. Barnes P. J., Karin M., Nuclear factor- B-a pivotal transcription factor in chronic inflammatory diseases. The New England Journal of Medicine 1997 336 15 1066 1071 2-s2.0-0030615201 10.1056/NEJM199704103361506 (Pubitemid 27163860)